The use of G-CSF in the prevention of febrile neutropenia
Perras C
Record ID 31998008138
English, French
Authors' objectives:
To identify the instances when the prophylactic use of G-CSF is justified by the reduced cost of treating febrile neutropenia.
Details
Project Status:
Completed
URL for project:
https://www.ccohta.ca/
Year Published:
1997
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Chemotherapy, Adjuvant
- Granulocyte Colony-Stimulating Factor
- Neutropenia
Contact
Organisation Name:
Canadian Coordinating Office for Health Technology Assessment
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553, Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Coordinating Office for Health Technology Assessment.
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.